On July 19th, Gelonhui reported that an investor asked a question through the interactive platform to Yantai Zhenghai Bio-Tech (300653.SZ): How is the promotion of biomaterials bones overseas? Is it authorized or self-promoted? When will the calcium-silicon bioceramic bone repair material be registered? What month is it available for sale???
Yantai Zhenghai Bio-Tech (300653.SZ) responded: Hello! According to relevant regulations, medical instrument products need to obtain the market access permit of the country in which they are sold overseas. As the first domestic bone filling product containing rhBMP-2 that specially binds with collagen, the activatable biologic bone has a high degree of innovation and has the potential for export overseas in the long term. The company's calcium-silicon bioceramic bone repair material is expected to be filed for registration this year. Thank you for your attention to the company!